Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review
Background: Endogenous Cushing's syndrome (CS), also called hypercortisolism, leads to a significant increase in mortality due to excessive cortisol production, which is mainly due to cardiovascular disease. CS complicated with cardiomyopathies, which is a rare and severe condition, has rarely...
Main Authors: | Sisi Miao, Lin Lu, Ling Li, Yining Wang, Zhaolin Lu, Huijuan Zhu, Linjie Wang, Lian Duan, Xiaoping Xing, Yong Yao, Ming Feng, Renzhi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.777964/full |
Similar Items
-
Cushing’s disease – cardiovascular and metabolic complications
by: Marta Izabela Mazur, et al.
Published: (2019-11-01) -
Metabolic complications of endogenous Cushing: patient selection for screening
Published: (2013-03-01) -
Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism
by: Xiaolin Sun, et al.
Published: (2021-02-01) -
Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
by: Camila Viecceli, et al.
Published: (2022-10-01) -
Fluconazole for Hypercortisolism in Cushing’s Disease: A Case Report and Literature Review
by: Yiming Zhao, et al.
Published: (2020-12-01)